TB Research

A novel synthesis of 2-arylbenzimidazoles in molecular sieves-MeOH system and their antitubercular activity

Chaturvedi AK, Verma AK, Thakur JP, Roy S, Bhushan Tripathi S, Kumar BS, Khwaja S, Sachan NK, et al. (13 authors)

Bioorganic & medicinal chemistry · 2018-08

Abstract

Arylbenzimidazoles have been synthesized as antimycobacterial agents. An efficient synthesis has been developed for 2-arylbenzimidazoles from o-phenylenediamines and aromatic aldehydes in molecular sieves-methanol system. The methodology is straightforward to get 2-arylbenzimidazoles (3a-3z) in excellent yields with high chemoselectivity over 2-aryl-1-benzylbenzimidazoles (4a-4z). All these benzimidazole analogues were evaluated against M. tuberculosis in BACTEC radiometric assay. The compounds 4y and 4z exhibited potential antitubercular activity against M. tuberculosis H 37 R V , MIC at 16 µM and 24 µM respectively. The best compound of the series i.e. compound 4y was well tolerated by Swiss-albino mice in acute oral toxicity. Compound 4y possessing a diarylbenzimidazole core, can further be optimized for better activity.

MeSH terms

  • Animals
  • Mice
  • Mycobacterium tuberculosis
  • Body Weight
  • Imidazoles
  • DNA Gyrase
  • Bacterial Proteins
  • Antitubercular Agents
  • Microbial Sensitivity Tests
  • Administration, Oral
  • Binding Sites
  • Protein Structure, Tertiary
  • Structure-Activity Relationship
  • Molecular Docking Simulation